Loading your page…
Each register with its number of medicines and a few of them.
Anvisa · 359 medicines
Health Canada · 224 medicines
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
SFDA · 163 medicines · Historical list
AEMPS · 160 medicines
CBG-MEB · 97 medicines
AIFA · 91 medicines
HSA · 47 medicines
FDA · 43 medicines
MS · 35 medicines · Historical list
ALIMS · 31 medicines
HALMED · 21 medicines
PHARMAC · 16 medicines
TFDA · 2 medicines · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
47 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| AMOXICAP 250 CAPSULE 250 mg | Singapore | 250 mg | capsule | Authorised | Goldplus Universal Pte LTD |
| AMOXICAP 500 CAPSULE 500 mg | Singapore | 500 mg | capsule | Authorised | Goldplus Universal Pte LTD |
| APO-AMOXI CAPSULE 250 mg | Singapore | 250 mg | capsule | Authorised | Pharmaforte Singapore Pte LTD |
| AMOXIGRAN GRANULES 125 mg/5 ml | Singapore | 125 mg/5 ml | granule, for suspension | Authorised | Goldplus Universal Pte LTD |
| AMOXIGRAN GRANULES 250 mg/5 ml | Singapore | 250 mg/5 ml | granule, for solution | Authorised | Goldplus Universal Pte LTD |
| APO-AMOXI FOR ORAL SUSPENSION 125 mg/5 ml | Singapore | 125 mg/5 ml | powder, for suspension | Authorised | Pharmaforte Singapore Pte LTD |
| APO-AMOXI FOR ORAL SUSPENSION 250 mg/5 ml | Singapore | 250 mg/5 ml | powder, for suspension | Authorised | Pharmaforte Singapore Pte LTD |
| Moxiclav 1G TabletsCombination | Singapore | 875.0 MG + 125.0 MG | tablet, film coated | Authorised | Medochemie Singapore Pte. LTD. |
| Moxiclav 625 TabletCombination | Singapore | 500 mg + 125 mg | tablet, film coated | Authorised | Medochemie Singapore Pte. LTD. |
| AMOCLA TABLETS 625 mgCombination | Singapore | 500 mg + 125 mg | tablet, film coated | Authorised | Pharmaforte Singapore Pte LTD |
| AMOXAPEN 250 FOR ORAL SUSPENSION 250 mg/5 ml | Singapore | 250MG/5ML | powder, for suspension | Authorised | Goldplus Universal Pte LTD |
| Amoklavin-Bid Film Coated Tablets 1000 MGCombination | Singapore | 875 mg + 125 mg | tablet, film coated | Authorised | Goldplus Universal Pte LTD |
| AMYN 250 CAPSULE 250 mg | Singapore | 250 mg | capsule | Authorised | Apotheca Marketing Pte LTD |
| AMYN 500 CAPSULE 500 mg | Singapore | 500 mg | capsule | Authorised | Apotheca Marketing Pte LTD |
| AUGMENTIN TABLET 1 gCombination | Singapore | 875 mg + 125 mg | tablet, film coated | Authorised | Glaxosmithkline Pte LTD |
| MOXILEN 250 CAPSULE 250 mg | Singapore | 250 mg | capsule | Authorised | Medochemie Singapore Pte. LTD. |
| Moxilen Capsule 500MG | Singapore | 500.00 MG | capsule | Authorised | Medochemie Singapore Pte. LTD. |
| MOXIPEN CAPSULE 250 mg | Singapore | 250 mg | capsule | Authorised | Apex Pharma Marketing Pte. LTD. |
| AUGMENTIN TABLET 625 mgCombination | Singapore | 500 mg + 125 mg | tablet, film coated | Authorised | Glaxosmithkline Pte LTD |
| BETAMOX GRANULES 125 mg/5 ml | Singapore | 125 mg/5 ml | granule, for suspension | Authorised | Duopharma (Singapore) Pte LTD |
| BETAMOX GRANULES 250 mg/5 ml | Singapore | 250 mg/5 ml | granule, for suspension | Authorised | Duopharma (Singapore) Pte LTD |
| Clamox Film-Coated Tablets 1GCombination | Singapore | 875mg + 125mg | tablet, film coated | Authorised | Goldplus Universal Pte LTD |
| Moxiclav Powder for Solution for Injection/ Infusion 1.2G/VialCombination | Singapore | 1000mg/vial + 200mg/vial | injection, powder, for solution | Authorised | Medochemie Singapore Pte. LTD. |
| MOXICLAV FORTE DRY POWDER FOR ORAL SUSPENSION 312.5 mg/5 mlCombination | Singapore | 250 mg/5 ml + 62.5 mg/5 ml | powder, for suspension | Authorised | Medochemie Singapore Pte. LTD. |
| Moxiclav Bis Dry Powder for Oral Suspension 457MG/5MLCombination | Singapore | 400mg/5ml + 57mg/5ml | powder, for suspension | Authorised | Medochemie Singapore Pte. LTD. |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
